Home | Publications | Research (R&D) | Pipeline place holder
place holder place holder

Pipeline

InterGenetics Incorporated Product Pipeline Analysis


Publication Date   August 2008
Publisher   Global Markets Direct
Product Type   Report
Pages   26
ISBN Number   not applicable
Product Code   GMD667
Ask a question about this product?

Price £505.00

approximately: $753 | €602

Summary


This report is an insightful source for data, analysis and strategic insights into a InterGenetics Incorporated's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reasons to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content


  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
    • 2.3 Financial Performance
    • 2.4 Industry Outlook - In Vitro Diagnostics
  • 3 Business Description
    • 3.1 Business Overview
    • 3.2 Major Products and Services
      • 3.2.1 Overview
  • 4 History
  • 5 Key Employees
  • 6 Key Employee Biographies
  • 7 Company Statement
  • 8 Locations And Subsidiaries
    • 8.1 Head Office
    • 8.2 Other Locations & Subsidiaries
  • 9 Recent Developments
    • 9.1 Financial Announcements
      • 9.1.1 Sep 07, 2005: InterGenetics Builds DNA Analysis And Genotyping Laboratory
    • 9.2 Product News
      • 9.2.1 Aug 04, 2008: InterGenetics Incorporated Widens Commercial Market For Distribution Of First Multi-Factor Genetics-Based Breast Cancer Risk Test
      • 9.2.2 Dec 18, 2007: InterGenetics Cancer Risk Detection Research Awarded Nearly $500,000 In Grants
      • 9.2.3 May 16, 2007: InterGenetics Research on OncoVue Published in CANCER, Journal of the American Cancer Society, Identifies Age-Specific Genetic Associations Involved in Determining Breast Cancer Risk
      • 9.2.4 May 31, 2005: Interactive Education And Genetic Testing To Take Center Stage In Cancer Prevention
  • 10 InterGenetics Incorporated Pipeline Products
    • 10.1 InterGenetics Incorporated Product Pipeline Analysis
      • 10.1.1 InterGenetics Incorporated Pipeline Products By Equipment Type
      • 10.1.2 InterGenetics Incorporated Pipeline Products By Development Stage
      • 10.1.3 InterGenetics Incorporated Pipeline Products By Therapy Area
      • 10.1.4 InterGenetics Incorporated Pipeline Products By News Summary
    • 10.2 OncoVue Ovarian
      • 10.2.1 Product Description
      • 10.2.2 Product Status
    • 10.3 OncoVue Colon
      • 10.3.1 Product Description
      • 10.3.2 Product Status
    • 10.4 OncoVue Lung
      • 10.4.1 Product Description
      • 10.4.2 Product Status
    • 10.5 OncoVue Prostrate
      • 10.5.1 Product Description
      • 10.5.2 Product Status
  • 11 Appendix
    • 11.1 Methodology
      • 11.1.1 Coverage
      • 11.1.2 Secondary Research
      • 11.1.3 Primary Research
      • 11.1.4 Expert Panel Validation
    • 11.2 Contact Us
    • 11.3 About Global Markets Direct
    • 11.4 Disclaimer
  • 1 List of Tables
    • Table 1: InterGenetics Incorporated,Key Facts
    • Table 2: InterGenetics Incorporated, Key Employees,
    • Table 3: InterGenetics Incorporated, Other Locations
    • Table 4: InterGenetics Incorporated Pipeline Products by Equipment Type
    • Table 5: InterGenetics Incorporated Pipeline Products By Development Stage
    • Table 6: InterGenetics Incorporated Pipeline Products By Therapy Area
    • Table 7: InterGenetics Incorporated Pipeline Products By News Summaries
    • 1.2 List of Figures
    • Figure 1: InterGenetics Incorporated Pipeline Products By Development Stage
    • Figure 2: InterGenetics Incorporated Pipeline Products By News Summary
    • Figure 3: Global Markets Direct Methodology